Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
R. Mark Adams currently holds 175,361 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, R. Mark Adams has been a net seller of ADPT stock. They have purchased $0 and sold $1.7M worth of shares.
R. Mark Adams's most recent insider trade was on Apr 11, 2023, when they sold 2,308 shares at $8.63 per share.
R. Mark Adams serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 25 insider transactions totaling $1.7M over their tenure at the company.
R. Mark Adams holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
R. Mark Adams has shown a selling trading pattern, with $0 in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by R. Mark Adams was on Jun 17, 2021, when they sold $583.3K worth of ADPT shares. This transaction involved 14,583 shares at $40.00 per share.
R. Mark Adams currently owns 175,361 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of R. Mark Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. R. Mark Adams has 25 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for R. Mark Adams and 40,000+ other insiders.